References

  1. Cutuli B. Le carcinomecanalaire in situ (CCIS). Cancer du sein: Springer Paris; 2006. PP 251. Google Scholar

  2. Tatjana M-H, Staubli M. Syndromes paranéoplasiques. Forum Med Suisse. 2002; 48: 1139-45. PubMed | Google Scholar

  3. Peterson K, Forstyth PA, Posner JB. Paraneoplastic sensorimotor neuropathy associated with breast cancer. Journal of neuro-oncology. 1994; 21(2): 159-70. PubMed | Google Scholar

  4. Rojas I, Graus F, Keime-Guilbert F, Rene R, Delatre JY, Ramon JM et al. Long term clinical outcome of paraneoplastic cerebellar degeneration and anti Yo antibodies. Neurology. 2000;55(5): 713-5. PubMed | Google Scholar

  5. Anderson NE, Rosenblum Mk, Prosper JB. Paraneoplastic cerebellar degeneration: clinical -immunological correlations. Annals of neurology. 1988; 24(4): 559- 67. PubMed | Google Scholar

  6. Shams'ili S, Grefkens J, de Leeuw B, Van den Bent M, Hooijkaas H, Van der Holt B et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain: a journal of neurology. 2003 ; 126 (pt 6):1409-18. PubMed | Google Scholar

  7. Dalmau J, Posner JB. Neurological paraneoplastic syndromes. [Journal Article, Review]Springer seminars in immunopathology. 1996; 18(1): 85-95. PubMed | Google Scholar

  8. Krakauer J, Balmaceda C, Gluck JT, Posner JB, Fetell MR, Dalmau J. Anti Yo associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of unknown origin. Neurology. 1996;46(5):1486-7. PubMed | Google Scholar

  9. Meglic B, Grauss F, Grad A. anti Yo associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. Journal of the neurogical sciences. 2001; 247(7):552-3. PubMed | Google Scholar

  10. Bechich S, Graus F, Arboix A, Isidro A, Marti M, Rosell F. Anti-Huassociatedparaneoplastic sensory neuropathy and breast cancer. J Neurol. 2000Jul; 247(7):552-3. PubMed | Google Scholar

  11. Escudero D, Barnadas A, Codina M, Fueyo J, Graus F. Anti-Ri associated paraneoplastic neurologic disorder without opsoclonus in a patient with breast cancer. Neurology. 1993; 43 (8):1605-6. PubMed | Google Scholar

  12. Tanaka K, Tanaka M, Onodera O, Igarashi S, Tsuji S. The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein. No to shinkei = brain and nerve. 1994; 46(1): 47-51. PubMed | Google Scholar

  13. Kaneko A, Nishikiori E, Imai A, Hosokawa T, Hamaguchi K. Antineuronal autoantibody to a 40-kda protein in a patient with cerebellar ataxia and breast cancer. Rinsho Shinkeigaku Clinical neurology. 1995; 35(3):277-81. PubMed | Google Scholar

  14. Wirtz Pw, Sillevis Smitt PA, Hoff JI, De Leeuw B, Lammers GJ, Van Duinen SG et al. Anti-RI antibody positive opsoclonus - myoclonus in a male patient with breast carcinoma. Journal of neurology. 2002; 249(12):1710-2. PubMed | Google Scholar

  15. Sutton I, Winer J, Rowlands D, Dalmau J. Limbic encephalitis and antibodies to Ma2: a paraneoplastic presentation of breast cancer. Journal of neurology, neurosurgery, and psychiatry. 2000; 69(2):1557-60. PubMed | Google Scholar

  16. Antoine JC. Paraneoplastic peripheral neuropathies. Revue neurologique. 2001; 157(12):1557-60. PubMed | Google Scholar

  17. Nagel GA. Immunosuppression: a paraneoplastic syndrome. Schweizerische medizinische Wochenschrift. 1971; 101(13):470-4. PubMed | Google Scholar

  18. Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Grauss F et al. Selective expression of Purkinje - cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. The New England journal of medicine. 1990; 322 (26): 1844-51. PubMed | Google Scholar

  19. Bartos A, Stourac P, Rusina R, Sejdova M, Velenska Z. Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma. Der Nervenarzt. 2002;73(10): 995-8. PubMed | Google Scholar

  20. Greenlee JE, Burns JB, Rose JW, Jaekle KA, Clawson. Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption. Acta neuropathologica. 1995;89(4):341-5. PubMed | Google Scholar

  21. Antoine JC, Honnorat J. Antineuronal antibodies and central nervous system diseases: contribution to diagnosis and pathophysiology. Revue neurologique. 2000; 156(1): 23-33. PubMed | Google Scholar

  22. Peterson K, Rosenblum MK, Kotanides H, Prosper JB. Paraneoplastic cerebellar degeneration: a clinical analysis of 55 anti-Yo antibody - positive patients. Neurology. 1992;42(10):1931-7. PubMed | Google Scholar

  23. Graus F, Vega F, Delattre JY, Bonaventura I, Rene R, Arbaiza D. Etall Plasmaheresis and antineoplastic treatment in CNS paraneoplastic syndromes with anti-neuronal autoantibodies. Neurology. 1992; 42(3 Pt1): 536-40. PubMed | Google Scholar